Patents-Review.com
ClassID:

118008 ⎘

C12Y404/01011 - CPC Classification

Classification description:

Carbon-sulfur lyases (4.4.1) Methionine gamma-lyase (4.4.1.11)

Recent Application in this class:
#1
20250352625
2025-11-20

METHODS AND COMPOSITIONS FOR METHIONINE RESTRICTION

 #2
20250302813
2025-10-02

RECOMBINANT METHIONINASE IN THE TREATMENT OF CANCER

 #3
20250101401
2025-03-27

ENGINEERED METHIONINE GAMMA LYASE VARIANTS

 #4
20240115673
2024-04-11

METHOD AND COMPOSITION FOR THE TREATMENT OF CANCER

 #5
20240102024
2024-03-28

RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF

 #6
20240060037
2024-02-22

MODIFIED ORGANISMS FOR ETHYLENE, ETHANE, AND METHANE BIOGENESIS AND METHODS FOR USE THEREOF

 #7
20230250451
2023-08-10

APPLICATION OF METHIONINASE GENE THERAPY IN TREATMENT OF MALIGNANT TUMOR

 #8
20230090705
2023-03-23

RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED WITH METHIONINE METABOLISM AND METHODS OF USE THEREOF

 #9
20230063093
2023-03-02

Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof

 #10
20220403362
2022-12-22

Engineered methionine gamma lyase variants

 #11
20220340891
2022-10-27

Composition for preventing age-related metabolic and tissue degenerative changes

 #12
20220040272
2022-02-10

METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION

 #13
20210330767
2021-10-28

Composition for the treatment of COVID-19 infection, and a method of treatment

 #14
20210254040
2021-08-19

Orally administered composition of methioninase enzyme

 #15
20210077542
2021-03-18

Use of genetically engineered bacterium of attenuated in for treating liver cancer

 #16
20210008114
2021-01-14

Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor

 #17
20190367902
2019-12-05

Bioresponsive particles

 #18
20190309271
2019-10-10

THERAPEUTIC CELL SYSTEMS AND METHODS FOR TREATING HOMOCYSTINURIA

 #19
20190153421
2019-05-23

Orally administered composition to lower serum methionine levels and method of use

 #20
20190000941
2019-01-03

Method of treating a mammal, including human, against cancer using methionine and asparagine depletion

 #21
20180344771
2018-12-06

Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor

 #22
20180008682
2018-01-11

USE OF GENETICALLY ENGINEERED STRAIN VNP20009-M IN PREVENTING AND TREATING CANCER METASTASIS

 #23
20170260518
2017-09-14

Methionine lyase, encoding gene and biosynthetic method thereof

 #24
20160361361
2016-12-15

Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor

 #25
20150376593
2015-12-31

Genetically engineered bacterium for treatment of breast cancer, method for constructing the bacterium, and applications thereof

 #26
20140140978
2014-05-22

Polypeptides isolated from and their use for the treatment of cancer

 #27
20140044771
2014-02-13

Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

 #28
20110002978
2011-01-06

ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF